文献速递流行病学与生物统计医学教育与科研方法

临床试验注册与纳入系统评价的试验中较低偏倚风险相关

Clinical trial registration was associated with lower risk of bias compared with non-registered trials among trials included in systematic reviews.
PubMed 文献 · J Clin Epidemiol · 2022-01-23

该研究基于2014至2019年发表的100篇Cochrane系统评价中的临床试验,发现1177项试验中368项(31%)已注册,注册试验在随机序列产生、分配隐藏、实施偏倚、检测偏倚和报告偏倚五个领域的高或不明确偏倚风险较低;前瞻性注册与较低的选择偏倚、实施偏倚和检测偏倚风险相关。

要点

  • 注册试验在六个偏倚领域中的五个高或不明确偏倚风险较低。
  • 整体偏倚风险上,注册试验高或不明确风险低于未注册试验(RR 0.29,95%CI 0.19-0.46)。
  • 前瞻性注册与较低的选择偏倚、实施偏倚和检测偏倚风险相关。

核心结论

  • 在近期发表的干预性系统评价纳入的大样本临床试验中,临床试验注册与六个 examined 偏倚领域中的五个较低偏倚风险相关。

研究设计与样本

  • 研究纳入2005年或之后发表的临床试验,这些试验来自2014至2019年发表的100篇Cochrane系统评价的样本。

主要发现

  • 共识别1177项临床试验,其中368项(31%)已注册,已注册试验中135项(36.7%)为前瞻性注册(即在首例参与者入组前或入组后1个月内注册)。
  • 各偏倚领域中,低风险试验百分比范围为29%至58%,不明确风险范围为26%至61%,高风险范围为2%至38%。
  • 注册试验在五个领域的高或不明确偏倚风险较低:随机序列产生(单变量RR 0.69,95%CI 0.58-0.81)、分配隐藏(RR 0.64,95%CI 0.57-0.72)、实施偏倚(RR 0.65,95%CI 0.58-0.72)、检测偏倚(RR 0.70,95%CI 0.62-0.78)和报告偏倚(RR 0.62,95%CI 0.53-0.73)。
  • 临床试验注册与高或不明确失访偏倚风险之间的关联既不能证实也不能否定(RR 1.02,95%CI 0.89-1.17)。
  • 注册试验的高或不明确整体偏倚风险低于未注册试验(单变量RR 0.29,95%CI 0.19-0.46)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the association between clinical trial registration and risk of bias in clinical trials that have been included in systematic reviews. As a secondary objective, we evaluated the risk of bias among trials registered prospectively vs. retrospectively. METHOD: Clinical trials published in 2005 or after included in a sample of 100 Cochrane systematic reviews published from 2014-2019. RESULTS: Of 1,177 clinical trials identified, we verified 368 (31%) had been registered, of which 135 (36.7%) were registered prospectively (i.e., before or up to 1 month after enrollment of the first participant). Across the bias domains (one bias assessment for each domain per trial), the percentage of trials at low risk ranged from 29% to 58%; unclear risk ranged from to 26% to 61% and high risk ranged from 2% to 38%. Trials that had been registered had less high or unclear risk of bias in five domains: random sequence generation (univariate risk ratio [RR] 0.69, 95% confidence interval [95% CI] 0.58-0.81), allocation concealment (RR 0.64, 95% CI 0.57-0.72), performance bias (RR 0.65, 95% CI 0.58-0.72), detection bias (RR 0.70, 95% CI 0.62-0.78), and reporting bias (RR 0.62, 95% CI 0.53-0.73). An association between clinical trial registration and high or unclear risk of attrition bias could not be demonstrated nor refuted (RR 1.02, 95% CI 0.89-1.17). It also was observed in terms of overall risk of bias, that registered trials had less high or unclear overall risk of bias than trials that had not been registered (univariate RR 0.29, 95% CI 0.19-0.46). Prospective clinical trial registration was associated with low risks of selection bias due to inadequate allocation concealment, performance bias, and detection bias compared with retrospective clinical trial registration. CONCLUSION: In a large sample of clinical trials included in recently published systematic reviews of interventions, clinical trial registration was associated with low risk of bias for five of the six domains examined.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Lindsley K, Fusco N, Li T, et al. Clinical trial registration was associated with lower risk of bias compared with non-registered trials among trials included in systematic reviews. J Clin Epidemiol. 2022. PMID: 35081449. doi:10.1016/j.jclinepi.2022.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。